CSIMarket
 


Tango Therapeutics Inc   (TNGX)
Other Ticker:  
 
 

TNGX's Revenue Growth by Quarter and Year

Tango Therapeutics Inc 's Revenue results by quarter and year




TNGX Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 6.41 -6.79 0.00
III Quarter September 10.73 6.92 6.79 0.00
II Quarter June 14.60 5.77 0.00 0.00
I Quarter March 5.77 5.76 0.00 0.00
FY   31.10 24.86 0.00 0.00



TNGX Revenue third quarter 2023 Y/Y Growth Comment
Tango Therapeutics Inc achieved in the third quarter 2023, above Company average Revenue rise of 55.09% year on year, to $ 10.73 millions.

Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 71 other companies have achieved higher Revenue growth. While Tango Therapeutics Inc ' s Revenue jump of 55.09% ranks overall at the positon no. 330 in the third quarter 2023.




TNGX Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September 55.09 % 1.91 % - -
II Quarter June 153.03 % - - -
I Quarter March 0.17 % - - -
FY   - - - -

Financial Statements
Tango Therapeutics Inc 's third quarter 2023 Revenue $ 10.73 millions TNGX's Income Statement
Tango Therapeutics Inc 's third quarter 2022 Revenue $ 6.92 millions Quarterly TNGX's Income Statement
New: More TNGX's historic Revenue Growth >>


TNGX Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -7.37 % - -
III Quarter September -26.49 % 19.93 % - -
II Quarter June 153.03 % 0.17 % - -
I Quarter March -9.98 % - - -
FY (Year on Year)   - - - -




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #72
Healthcare Sector #129
Overall #330

Revenue Y/Y Growth Statistics
High Average Low
152.95 % 52.53 % 0.14 %
(Jun 30 2023)   (Mar 31 2023)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #72
Healthcare Sector #129
Overall #330
Revenue Y/Y Growth Statistics
High Average Low
152.95 % 52.53 % 0.14 %
(Jun 30 2023)   (Mar 31 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Tango Therapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
153.17 % 21.57 % -26.48 %
(Jun 30 2023)  


TNGX's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Tango Therapeutics Inc realized fall in Revenue from the previous quarter by -26.49% to $ 10.73 millions, from $ 14.60 millions achived in the previous reporting period.

Some cyclical circumstance which commonly elevate III. Quarter 2023 results, could not salvage the III. Quarter for the Tango Therapeutics Inc , Marc Pérez, Major Pharmaceutical Preparations industry expert pointed out and mentioned that average sequential Revenue growth is at 21.57% for the Major Pharmaceutical Preparations's company.

Within Major Pharmaceutical Preparations industry 106 other companies have achieved higher Revenue quarter on quarter growth. While Tango Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 2226.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #107
Healthcare Sector #308
Overall #2226
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #107
Healthcare Sector #308
Overall #2226
Revenue Q/Q Growth Statistics
High Average Low
153.17 % 21.57 % -26.48 %
(Jun 30 2023)  


TNGX's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Tango Therapeutics Inc realized fall in Revenue from the previous quarter by -26.49% to $ 10.73 millions, from $ 14.60 millions declared a quarter before.

Some seasonal circumstance which normally fuel III. Quarter 2023 results, were not able to recover the III. Quarter for the Tango Therapeutics Inc , Marc Pérez, Major Pharmaceutical Preparations industry expert wrote and mentioned that average quarter on quarter Revenue growth is at 21.57% for the Major Pharmaceutical Preparations's company.

Within Major Pharmaceutical Preparations industry 106 other companies have achieved higher Revenue quarter on quarter growth. While Tango Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 2226.


Tango Therapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 37.51 $ 33.70 $ 24.87 $ 24.86 $ 11.66
Y / Y Revenue Growth (TTM) 221.62 % 192.26 % - - -
Year on Year Revenue Growth Overall Ranking # 50 # 163 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 11.31 % 35.5 % 0.03 % 113.17 % 1.15 %
Seq. Revenue Growth (TTM) Overall Ranking # 2065 # 2127 # 2090 # 2062 # 2117




Cumulative Revenue growth Comment
With 221.62% annual Revenue growth, Tango Therapeutics Inc would report a record annual Revenue surge if the fiscal year would end on Sep 30 2023.

Among companies within the Healthcare sector 19 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 50, from total ranking in previous quarter at 163.

Revenue TTM Q/Q Growth Statistics
High Average Low
221.62 %
206.94 %
192.26 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 125
Healthcare Sector # 20
Overall # 50

Revenue TTM Y/Y Growth Statistics
High Average Low
221.62 %
206.94 %
192.26 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 342
S&P 500 # 2065
Cumulative Revenue growth Comment
With 221.62% annual Revenue growth, Tango Therapeutics Inc would report a record annual Revenue surge if the fiscal year would end on Sep 30 2023.

Among companies within the Healthcare sector 19 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 50, from total ranking in previous quarter at 163.

Revenue TTM Q/Q Growth Statistics
High Average Low
221.62 %
206.94 %
192.26 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 125
Healthcare Sector # 20
Overall # 50

Revenue TTM Y/Y Growth Statistics
High Average Low
221.62 %
206.94 %
192.26 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 342
S&P 500 # 2065




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TNGX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for TNGX's Competitors
Revenue Growth for Tango Therapeutics Inc 's Suppliers
Revenue Growth for TNGX's Customers

You may also want to know
TNGX's Annual Growth Rates TNGX's Profitability Ratios TNGX's Asset Turnover Ratio TNGX's Dividend Growth
TNGX's Roe TNGX's Valuation Ratios TNGX's Financial Strength Ratios TNGX's Dividend Payout Ratio
TNGX's Roa TNGX's Inventory Turnover Ratio TNGX's Growth Rates TNGX's Dividend Comparisons



Companies with similar Revenue surge for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Revance Therapeutics Inc 95.68%$ 95.678 millions
Evoke Pharma Inc 87.82%$ 87.821 millions
Xoma Corporation84.04%$ 84.035 millions
Catalyst Pharmaceuticals Inc 79.39%$ 79.386 millions
Esperion Therapeutics inc 78.97%$ 78.973 millions
Docgo Inc 78.83%$ 78.828 millions
Precision Biosciences Inc78.19%$ 78.188 millions
Marpai Inc 76.77%$ 76.771 millions
Bicycle Therapeutics Plc76.05%$ 76.053 millions
Intra cellular Therapies Inc 75.56%$ 75.557 millions
Agilon Health Inc 74.95%$ 74.951 millions
Rxsight Inc 72.26%$ 72.263 millions
Elite Pharmaceuticals Inc 71.86%$ 71.860 millions
Procept Biorobotics Corporation71.38%$ 71.379 millions
Pacific Biosciences Of California Inc 69.92%$ 69.917 millions
Biocardia Inc68.40%$ 68.396 millions
Xtant Medical Holdings Inc 68.26%$ 68.262 millions
Cvrx inc67.98%$ 67.978 millions
Merus N v 67.65%$ 67.649 millions
Alimera Sciences Inc 66.25%$ 66.245 millions
Coherus Biosciences inc 64.16%$ 64.160 millions
C4 Therapeutics Inc 63.93%$ 63.932 millions
Y mabs Therapeutics inc 63.15%$ 63.149 millions
Nanostring Technologies Inc 62.79%$ 62.787 millions
Xeris Biopharma Holdings Inc 62.56%$ 62.557 millions
Adma Biologics Inc 62.21%$ 62.211 millions
Acadia Pharmaceuticals Inc 61.96%$ 61.956 millions
Orthofix Medical Inc 61.20%$ 61.201 millions
Molecular Templates inc 60.28%$ 60.283 millions
Sintx Technologies Inc 59.15%$ 59.155 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com